Takeda Acquires U.S. Biologics Manufacturing Facility

News   Jan 07, 2016

 
Takeda Acquires U.S. Biologics Manufacturing Facility
 
 
 

RELATED ARTICLES

Putting the Brain at the Center of Anesthesiology

News

Emery N. Brown explains how statistics and neuroscience improve anesthesiology at the American Association for the Advancement of Science's annual meeting.

READ MORE

Absolute Antibody and Kerafast Merge Increasing Access to Unique Reagents and Recombinant Antibody Technology

News

Absolute Antibody Ltd., and Kerafast Inc., have announced a merger of the two companies. The merger brings together two companies with a shared commitment to improving the selection of research tools available to the scientific community.

READ MORE

No Llamas Required

News

Detouring around a major research roadblock, researchers have found a new way to create valuable antibodies without needing … llamas? It is a little-known fact that llamas, alpacas, camels and other members of the camelid family make a unique class of antibodies that allow scientists to determine the structures of otherwise impossible-to-study proteins in the body, helping them to understand how those proteins malfunction in disease and how to design new drugs that act on them.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE